LAKE BLEU CAPITAL (HONG KONG) LIMITED

Thesis

Lake Bleu Capital is a Hong Kong-based asset management firm focused on healthcare investments in Asia, particularly Greater China. They employ a long-term strategy across public and private equity, targeting mid- to late-stage companies and healthcare technology innovation. The firm acts as a cornerstone investor in public offerings, leveraging deep scientific and financial expertise to identify high-growth potential companies. They conduct rigorous fundamental research and provide strategic guidance, benchmarking Chinese innovations against global standards. The firm operates in Hong Kong and Shanghai and manages billions of US dollars in assets, with specific funds like the Lake BLEU Innovation Healthcare Fund Limited ($100M) and LBC Sunshine Healthcare Fund II LP ($560M). Their estimated net worth was at least $345 million as of June 2026. They hold a Type 9 license from the Hong Kong SFC and serve professional investors.